IMPLANTABLE NEUROSTIMULATOR
Report
- Report Number
- 2182207-2020-00122
- Event Type
- Injury
- Date Received
- April 8, 2020
- Date of Event
- February 17, 2020
- Report Date
- April 8, 2020
- Manufacturer
- MEDTRONIC NEUROMODULATION
- Product Code
- MHY
- PMA / PMN Number
- P960009
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FI
- Reporter Occupation
- OTHER
Narratives
CONCOMITANT MEDICAL PRODUCTS: PRODUCT ID: 3389, SERIAL/LOT #: UNKNOWN. PRODUCT ID: 3389, SERIAL/LOT #: UNKNOWN. PRODUCT ID: NEU_INS_STIMULATOR, SERIAL/LOT #: UNKNOWN. PRODUCT ID: NEU_INS_STIMULATOR, SERIAL/LOT #: UNKNOWN. PRODUCT ID: NEU_INS_STIMULATOR, SERIAL/LOT #: UNKNOWN. AGE. THIS VALUE IS THE AVERAGE AGE OF THE PATIENTS REPORTED IN THE ARTICLE AS SPECIFIC PATIENTS COULD NOT BE IDENTIFIED. SEX. THIS VALUE REFLECTS THE GENDER OF THE MAJORITY OF THE PATIENTS REPORTED IN THE ARTICLE AS SPECIFIC PATIENTS COULD NOT BE IDENTIFIED. DATE OF EVENT. PLEASE NOTE THAT THIS DATE IS BASED OFF OF THE DATE THAT THE ARTICLE WAS ACCEPTED FOR PUBLICATION AS THE EVENT DATES WERE NOT PROVIDED IN THE PUBLISHED LITERATURE. IT WAS NOT POSSIBLE TO ASCERTAIN SPECIFIC DEVICE INFORMATION FROM THE ARTICLE OR TO MATCH THE EVENTS REPORTED WITH PREVIOUSLY REPORTED EVENTS. CORRESPONDENCE HAS BEEN SENT TO THE AUTHOR OF THE ARTICLE INQUIRING ABOUT INDIVIDUAL PATIENT INFORMATION AND ADDITIONAL INFORMATION REGARDING THE REPORTED EVENTS. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. (B)(4).
LAHTINEN MJ, HAAPANIEMI TH, KAUPPINEN MT, SALOKORPI N, HEIKKINEN ER, KATISKO JP. A COMPARISON OF INDIRECT AND DIRECT TARGETED STN DBS IN THE TREATMENT OF PARKINSON'S DISEASE-SURGICAL METHOD AND CLINICAL OUTCOME OVER 15-YEAR TIMESPAN. ACTA NEUROCHIR (WIEN). 2020. 1 0.1007/S00701-020-04269-X SUMMARY: DEEP BRAIN STIMULATION (DBS) IN THE SUBTHALAMIC NUCLEUS (STN) IS USED IN ADVANCED PARKINSON¿S DISEASE (PD) FOR REDUCING MOTOR FLUCTUATIONS AND THE SIDE EFFECTS OF ANTIPARKINSONIAN MEDICATION (APM). THE DEVELOPMENT OF NEUROIMAGING HAS ENABLED THE DIRECT TARGETING OF THE STN. THE AIM OF THIS STUDY IS TO EVALUATE THE OUTCOME IN PATIENTS WITH PD USING STN DBS WHEN CHANGING FROM ATLAS-BASED INDIRECT TARGETING METHOD (ITM) TO DIRECT MRI-BASED TARGETING (DTM) ASSUMING DTMIS SUPERIOR. IDENTIFIED EVENTS: 2 PATIENTS HAD AN EARLY SURGICAL SITE INFECTION FOLLOWED BY SURGICAL REVISION WITH PARTIAL OR TOTAL DBS REMOVAL AND CESSATION OF THE STIMULATION. BOTH OF THE PATIENTS WERE RE-IMPLANTED SUCCESSFULLY FOLLOWING ANTIBIOTIC TREATMENT. 1 PATIENT SUFFERED FROM A TECHNICAL FAILURE OF THE DBS DEVICE, WHICH WAS NOTED AS BEING A LEAD FRACTURE FOLLOWED BY CESSATION OF THE STIMULATION OR SELECTION OF NON-OPTIMAL ACTIVE CONTACT. THE PATIENT WAS RE-IMPLANTED SUCCESSFULLY BUT 12-MONTH EVALUATION WAS EXCEEDED. 1 PATIENT SUFFERED FROM A TECHNICAL FAILURE OF THE DBS DEVICE, WHICH WAS NOTED AS BEING CONTACT DAMAGE FOLLOWED BY CESSATION OF THE STIMULATION OR SELECTION OF NON-OPTIMAL ACTIVE CONTACT. THE PATIENT GOT A SATISFACTORY RESPONSE TO TREATMENT BY ALTERING THE PROGRAMMING. 1 PATIENT SUFFERED FROM POSTOPERATIVE UNILATERAL CHRONIC SUBDURAL HEMATOMA, WHICH DID NOT REQUIRE AND SURGICAL INTERVENTION NOR DID IT AFFECT THE CLINICAL OUTCOME. 1 PATIENT SUFFERED FROM POSTOPERATIVE ACUTE HEMORRHAGE ALONGSIDE THEIR UNILATERAL ELECTRODE. THIS CAUSED A SLIGHT TRANSIENT CONFUSION, WHICH DID NOT AFFECT THE CLINICAL ASSESSMENT. 1 PATIENT SUFFERED FROM POSTOPERATIVE ACUTE HEMORRHAGE ALONGSIDE THEIR BILATERAL ELECTRODE. THIS PATIENT HAD A SUBCLINICAL VITAMIN K DEFICIENCY DIAGNOSED AFTER POSTOPERATIVE EVALUATION. THE FOLLOWING DEVICE SPECIFICS WERE PROVIDED: LEAD MODEL 3389.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 398874 | IMPLANTABLE NEUROSTIMULATOR | STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR | MHY | MEDTRONIC NEUROMODULATION | NEU_INS_STIMULATOR |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 61 YR | Required Intervention |